• Danaher Reports Record Q4 and Full Year 2013 Results

      Danaher Corp. has today reported record results both for the final quarter and for the full year. H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, “Our strong finish in 2013 contributed to a solid year for Danaher overall.  Our team’s application of the Danaher Business System drove relative top line outperformance, solid […]

  • VP of Sales – New Job

      Our client is a European global technology company developing innovative analytical products with applications in the pharmaceutical industry and airport security markets. The company is growing and has a requirement to find an experienced VP of Sales for its global sales activities. For more information please contact us.

  • North American Sales Manager – New Job

    Seeking a North American Sales Manager. Do you have recent experience selling capital scientific instrumentation in the North American pharma market? Do you have recent experience working as a North American Sales Manager or North American Regional Sales Manager? Do you have experience with vibrational spectroscopy instruments? Do you understand the needs of the QA/QC […]

  • Industry Insight – An Interview with Tom Warwick

    Tom Warwick has held various sales and marketing positions throughout his career in the scientific laboratory instrumentation market. Having worked his way through the ranks with companies such as Uson, Oxford Instruments and Veeco Instruments, Tom has gained considerable experience in a range of product/application markets in most parts of the world. Here, he talks with Peter Booth and shares some of that experience. […]

  • Life Technologies Stockholders Approve Acquisition by Thermo Fisher

      CARLSBAD, Calif., Aug. 21, 2013 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced that its stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Life Technologies by Thermo Fisher Scientific (NYSE: TMO) at the Special Meeting of Stockholders held earlier today. More than 98 percent of votes cast at the Special Meeting […]

  • Agilent Reports Q3 2013 Results

      Agilent Technologies Inc. (NYSE: A) today reported orders of $1.60 billion, down 4 percent compared with one year ago, and revenues of $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago. Third-quarter GAAP net income was $168 million, or $0.49 per share. Last year’s third-quarter […]

  • FEI Reports Q2 2013 Results

      For the second quarter ended June 30, 2013, FEI Company (Nasdaq:FEIC) reported bookings that were the highest for any quarter in the company’s history as well as improved gross margins and strong cash flow from operations. Revenue of $222.5 million was a record for a second quarter and was up slightly compared to $221.5 […]

  • Bruker Reports Q2 2013 Results

      Revenues for the second quarter of 2013 grew by 8.1 percent to $454.9 million, compared to$420.7 million in the second quarter of 2012. Excluding a 0.8 percent negative effect from changes in foreign exchange rates and a 0.6 percent net negative effect from acquisitions and divestitures, Bruker generated organic revenue growth of 9.5 percent in the second quarter […]

  • Harvard Bioscience Reports Q2 2013 Results

      Revenues for the three months ended June 30, 2013 were $26.1 million, a decrease of $2.4 million, or 8.4% compared to revenues of $28.5 million for the three months ended June 30, 2012. Currency exchange rates had a negative 0.2% effect on revenues compared with the second quarter of 2012. Excluding the effects of […]

  • Coherent Reports Q3 2013 Results

      For the third fiscal quarter ended June 29, 2013, Coherent announced net sales of $213.7 million and net income, on a U.S. GAAP basis, of $16.7 million, or $0.68 per diluted share.  These results compare to net sales of $196.4 million and net income of $17.2 million, or $0.72 per diluted share, for the […]

  • Spectris Reports Q2 2013 Results

      Commenting on the results, John O’Higgins, Chief Executive, said: “Trading improved during the second quarter across all segments. We remain encouraged both by the strong overall level of our opportunity pipeline and the expected delivery of our planned £10 million net cost savings for the full year. Our businesses are strategically well positioned and, […]

  • Mettler Toledo Reports Q2 2013 Results

      Olivier Filliol, President and Chief Executive Officer, stated, “Market conditions remain challenging, particularly in China.  However, with the continued strong execution in our various margin improvement and cost control initiatives, we generated good growth in EPS.” EPS in the second quarter was $2.24, compared with the prior-year amount of $1.93.  Adjusted EPS was $2.35, an increase of […]